Cardiovascular effects of sulphonylurea derivatives.
Smits
P
P
Department of Pharmacology, University of Nijmegen, The Netherlands.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005905:Glyburide / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015221:Potassium Channels / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D015221:Potassium Channels; D013453:Sulfonylurea Compounds; C057619:glimepiride; D000255:Adenosine Triphosphate; D005905:Glyburide